NCT04734730
- Conditions
- Castration-Sensitive Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +12 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Clinical trial condition
Metastatic Prostate Adenocarcinoma
Explore clinical trials studying Metastatic Prostate Adenocarcinoma. Study availability and eligibility vary by location and protocol.
25 public trials
14 recruiting studies
Metastatic Prostate Adenocarcinoma trial results
NCT05796973
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Cancer, +42 more
- Locations
-
- Tampere University Hospital Tampere, Länsi-Suomi, Finland
NCT06850545
- Conditions
- Metastatic Prostate Adenocarcinoma, PSMA PET-Positive Castration-Resistant Prostate Cancer
- Locations
-
- Kuopio University Hospital Kuopio, Northern Savonia, Finland
NCT05054296
- Conditions
- Biochemically Recurrent Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +12 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis
NCT03317392
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
- Yale University New Haven, Connecticut, United States
Active, not recruiting
ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT04471974
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +13 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- University of Chicago Evergreen Park, Illinois, United States
- University of Michigan Ann Arbor, Michigan, United States
Active, not recruiting
A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer
NCT04190446
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Active, not recruiting
A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy
NCT04455750
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +12 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
Active, not recruiting
Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer
NCT03902951
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
Active, not recruiting
Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies
NCT03611686
- Conditions
- Metastatic Prostate Adenocarcinoma
- Locations
-
- Rouen University Hospital Rouen, France